reneuron (uk) limited
reneuron (uk) limited Company Information
Company Number
04083134
Next Accounts
78 days late
Shareholders
reneuron holdings ltd
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
c/o cork gully llp, 40 villiers street, london, WC2N 6NJ
Website
www.reneuron.comreneuron (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of RENEURON (UK) LIMITED at £0 based on a Turnover of £0 and 1.35x industry multiple (adjusted for size and gross margin).
reneuron (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of RENEURON (UK) LIMITED at £0 based on an EBITDA of £0 and a 5.31x industry multiple (adjusted for size and gross margin).
reneuron (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of RENEURON (UK) LIMITED at £0 based on Net Assets of £0 and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Reneuron (uk) Limited Overview
Reneuron (uk) Limited is a live company located in london, WC2N 6NJ with a Companies House number of 04083134. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2000, it's largest shareholder is reneuron holdings ltd with a 100% stake. Reneuron (uk) Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Reneuron (uk) Limited Health Check
There is insufficient data available to calculate a health check for Reneuron (Uk) Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Reneuron (uk) Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Reneuron (uk) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Reneuron (uk) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Reneuron (uk) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Reneuron (uk) Limited
- - Industry AVG
RENEURON (UK) LIMITED financials
Reneuron (Uk) Limited's latest turnover from March 2023 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Reneuron (Uk) Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | 2,066,000 | |||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | 2,066,000 | |||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | 2,066,000 | |||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | 2,066,000 | |||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | ||||||||||||||
| EBITDA* | 2,066,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||||||||
| Intangible Assets | ||||||||||||||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||
| Total Fixed Assets | ||||||||||||||
| Stock & work in progress | ||||||||||||||
| Trade Debtors | ||||||||||||||
| Group Debtors | 19,554,000 | 19,554,000 | 19,554,000 | 19,554,000 | ||||||||||
| Misc Debtors | ||||||||||||||
| Cash | ||||||||||||||
| misc current assets | ||||||||||||||
| total current assets | 19,554,000 | 19,554,000 | 19,554,000 | 19,554,000 | ||||||||||
| total assets | 19,554,000 | 19,554,000 | 19,554,000 | 19,554,000 | ||||||||||
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | ||||||||||||||
| Group/Directors Accounts | 2,066,000 | 2,066,000 | 2,066,000 | 2,066,000 | ||||||||||
| other short term finances | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| other current liabilities | ||||||||||||||
| total current liabilities | 2,066,000 | 2,066,000 | 2,066,000 | 2,066,000 | ||||||||||
| loans | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | ||||||||||||||
| total long term liabilities | ||||||||||||||
| total liabilities | 2,066,000 | 2,066,000 | 2,066,000 | 2,066,000 | ||||||||||
| net assets | 17,488,000 | 17,488,000 | 17,488,000 | 17,488,000 | ||||||||||
| total shareholders funds | 17,488,000 | 17,488,000 | 17,488,000 | 17,488,000 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 2,066,000 | |||||||||||||
| Depreciation | ||||||||||||||
| Amortisation | ||||||||||||||
| Tax | ||||||||||||||
| Stock | ||||||||||||||
| Debtors | -19,554,000 | 19,554,000 | ||||||||||||
| Creditors | ||||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| Deferred Taxes & Provisions | ||||||||||||||
| Cash flow from operations | 21,620,000 | -19,554,000 | ||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | -2,066,000 | 2,066,000 | ||||||||||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | ||||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | -21,620,000 | 19,554,000 | ||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | ||||||||||||||
| overdraft | ||||||||||||||
| change in cash |
reneuron (uk) limited Credit Report and Business Information
Reneuron (uk) Limited Competitor Analysis
Perform a competitor analysis for reneuron (uk) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in WC2N area or any other competitors across 12 key performance metrics.
reneuron (uk) limited Ownership
RENEURON (UK) LIMITED group structure
Reneuron (Uk) Limited has no subsidiary companies.
Ultimate parent company
2 parents
RENEURON (UK) LIMITED
04083134
reneuron (uk) limited directors
Reneuron (Uk) Limited currently has 2 directors. The longest serving directors include Ms Catherine Isted (Oct 2021) and Mr Iain Ross (Dec 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Catherine Isted | United Kingdom | 49 years | Oct 2021 | - | Director |
| Mr Iain Ross | United Kingdom | 71 years | Dec 2022 | - | Director |
P&L
March 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
0
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
reneuron (uk) limited company details
company number
04083134
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
September 2000
age
25
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
March 2023
previous names
reneuron holdings plc (October 2003)
reneuron holdings limited (November 2000)
accountant
-
auditor
-
address
c/o cork gully llp, 40 villiers street, london, WC2N 6NJ
Bank
-
Legal Advisor
-
reneuron (uk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to reneuron (uk) limited.
reneuron (uk) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RENEURON (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
reneuron (uk) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
